I know this subject has appeared in the past, but I was wondering if anyone
could point me in the direction of the latest information on the use of
Lucozade in OGTTs - different formulations and volumes etc that can be used.
I have tried various other avenues and hit several brick walls so far!
We are auditing how our GPs perform OGTTs, so I would also be interested to
hear from anyone who has done anything similar, or whether labs produce
guidance for their GPs and/or patients on the procedure. We were interested
to note that the WHO criteria document
(http://www.who.int/diabetes/currentpublications/en/) does not specifically
state the levels of activity permissible during the test, or whether the patient
can eat or drink during the 2 hours!
Many thanks, Fiona
Dr Fiona Riddoch
Senior Clinical Biochemist
Department of Clinical Biochemistry & Immunology
x 3299 (direct dial 020 8934 3299)
ACB South London Trainee Representative
------ACB discussion List Information--------
This is an open discussion list for the academic and clinical
community working in clinical biochemistry.
Please note, archived messages are public and can be viewed
via the internet. Views expressed are those of the individual and
they are responsible for all message content.
ACB Web Site
List Instructions (How to leave etc.)